About
Team
Pipeline
OPN-2853
OPN-6602
OPN-FMRP
OPN-7486
OPN-9840
OPN-9627
Patients
News
Press Releases
Publications
& Posters
Careers
Contact
General information
info@opnabio.com
Investor inquiries
bd@opnabio.com
Media and BD inquiries
bd@opnabio.com
OPN-7486
Select PROGRAMS
All Programs
OPN-2853
(9)
OPN-51107
(17)
OPN-6602
(3)
OPN-7486
(5)
OPN-TEAD
(1)
Select Dates
All Dates
2024
(4)
2023
(3)
2022
(1)
2021
(3)
2020
(3)
2019
(7)
2018
(4)
2017
(3)
2016
(2)
2015
(3)
August 23, 2018
Publication
ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition
AUTHORS
Roberts, et al
Programs
OPN-7486
https://doi.org/10.1182/blood-2018-05-849554
June 6, 2018
Publication
Blocking colony stimulating factor 1 receptor (CSF-1R) and tropomyosin receptor kinase A (TrkA) improves the antitumor efficacy of immune checkpoint blockade
AUTHORS
Duffy, et al
Programs
OPN-7486
https://www.jimmunol.org/content/200/1_Supplement/122.15/tab-article-info
December 14, 2017
Publication
b2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer
AUTHORS
Renz, et al
Programs
OPN-7486
https://doi.org/10.1016/j.ccell.2017.11.007
January 9, 2017
Publication
Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling
AUTHORS
Hayakawa, et al
Programs
OPN-7486
https://doi.org/10.1016/j.ccell.2016.11.005
April 15, 2015
Publication
Cross Talk between Neuroregulatory Molecule and Monocyte: Nerve Growth Factor Activates the Inflammasome
AUTHORS
Datta-Mitra, et al
Programs
OPN-7486
https://doi.org/10.1371/journal.pone.0121626